Echo-EGD in the Community ASC: Democratizing Advanced GI Diagnostics

Coming off the floor at Florida Live Endoscopy 2026, and reviewing the latest clinical and outcomes data from community-based settings, the paradigm shift toward Echo-EGD is fundamentally reshaping how we approach diagnostic upper endoscopy. Spearheaded by investigators like Stuart Akerman, MD, and Stephen Steinberg, MD, at Digestive Health Associates of Texas, operating out of Digestive Health Centers of Plano and Allen, recent data proves that advanced endoscopic ultrasound no longer needs to be sequestered behind the high-cost barriers of tertiary care hospitals.

A recent prospective observational study tracking 249 consecutive endoscopic ultrasound procedures performed across community ambulatory surgical centers in Plano and Allen, Texas, highlights a game-changing safety profile with zero complications across all cases, meaning no instances of post-procedural pancreatitis, bleeding, perforation, or unplanned hospital admissions, with all patients safely discharged home. This cohort demonstrated a high diagnostic yield, identifying significant pathology in 39.8% of patients, including pancreatic cysts, chronic pancreatitis, bile duct dilation, and a pancreatic neuroendocrine tumor, driven by indications such as high-risk pancreatic cancer screening, abdominal pain, and evaluation of prior cross-sectional imaging. This was achieved using the vendor-agnostic EndoSound Vision System, which attaches directly to standard endoscopes rather than requiring a dedicated, four-hundred-thousand-dollar echoendoscope system, allowing facilities to achieve a 40 to 60 percent cost reduction compared to hospital-based procedures.

For decades, traditional endoscopic ultrasound has been bottlenecked by equipment costs, but the conceptual foundation of adding ultrasound to a standard diagnostic upper endoscopy is over 20 years old, dating back to foundational literature in 2000 by Anand Sahai, Robert Hawes, and colleagues. While a standard upper endoscopy evaluates only the luminal mucosa of the esophagus and stomach, Echo-EGD expands that window to capture vital surrounding structures such as the pancreas, liver, gallbladder, and regional lymph nodes during a single session. Seminal studies like the 2013 EFRAIM trial demonstrated that Echo-EGD has a significantly higher diagnostic yield than the combination of transabdominal ultrasound and standard upper endoscopy when evaluating right-sided and acute upper abdominal misery.

By shifting appropriate advanced imaging out of hospital settings and into optimized ambulatory surgical center environments, the cost structure drops dramatically for both insurers and patients, all while streamlining procedural workflows. Removing capital equipment lock-ins allows community gastroenterologists to offer tertiary-level diagnostic power locally, directly closing the care gap for underserved populations and proving that the future of gastroenterology relies on practical, cost-effective tools that make everyday endoscopy suites safer, more efficient, and far easier to run.

Experience a smarter way to source endoscopy equipment—all in one place.

✔ Wide selection of trusted endoscopy brands

✔ Competitive pricing without compromising quality

✔ Fast, reliable access to the tools you need—when you need them

👉 Explore how EndoPro® 3D can transform your surgical technique.